Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating radiation plus cetuximab for locally advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 study of tipifarnib (R115777) in recurrent or metastatic non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase II trial evaluating the combination of radiotherapy and gefitinib (Iressa) in EGFR mutation-positive locally advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone [Phase 3]
A Phase 3 study comparing erlotinib plus SU011248 versus erlotinib alone in patients with non-small cell lung cancer; results were posted in…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058) [Phase 1]
This Phase 1 trial update reports results for MK0683 in combination with FDA-approved cancer drugs in patients with advanced non-small cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib for leptomeningeal carcinomatosis in EGFR-mutant non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of TLK286 administered weekly in advanced non-small cell lung cancer has completed.
-
FDA approval · 2011-07-25FDA Approved: GEMCITABINE HYDROCHLORIDE — Original Application (Teyro Labs Private Limited)
The FDA approved an original ANDA for gemcitabine hydrochloride from Teyro Labs Private Limited, enabling its generic use.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1-2a dose-ranging study evaluating TLK286 in combination with docetaxel in platinum-resistant non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated TLK286 (Telcyta) in combination with cisplatin for locally advanced or metastatic non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression [Phase 2]
Phase 2 trial comparing pemetrexed/cisplatin versus gemcitabine/cisplatin in non-small cell lung cancer, with analysis by thymidylate syntha…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel plus carboplatin with or without Endostar in advanced non-small cell lung cancer has completed. The docu…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Phase I Cetuximab and Concurrent Radio-chemotherapy [Phase 1]
Phase I trial evaluating cetuximab with concurrent radiochemotherapy in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 study evaluating zoledronic acid to prevent or delay bone metastasis in stage IIIA/IIIB non-small cell lung cancer has completed, …
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating concurrent and non-concurrent chemo-radiotherapy or radiotherapy alone for oligo-metastatic stage IV non-small ce…
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating chemotherapy for non-small cell lung cancer has completed and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-07-18Clinical Trial Update: A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung Cancer [Phase 3]
Phase 3 study evaluating induction and maintenance therapy for advanced non-squamous non-small cell lung cancer has completed with results p…
-
CLINICAL_TRIALS research · 2011-07-18Clinical Trial Update: Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer [NA]
The trial compares endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) against mediastinoscopy for staging and detection of non-…
-
CLINICAL_TRIALS withdrawal · 2011-07-14Clinical Trial Update: Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer
A clinical trial evaluating the effects of radiation therapy on the body in patients with stage III non-small cell lung cancer has been with…
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy [Phase 2]
Phase II results from a maintenance therapy study of Zactima for locally advanced or metastatic non-small-cell lung cancer following platinu…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]
This report summarizes a completed dose-escalation Phase 1/2 trial of patupilone given every three weeks in patients with non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study of nimotuzumab in combination with external radiotherapy for non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases [Phase 2]
Phase 2 trial evaluating nimotuzumab with radiation therapy for brain metastases in metastatic non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) [NA]
This clinical trial update reports a completed study of GV-1001 immunotherapy in patients with Non-Small Cell Lung Cancer. The document prov…
-
FDA approval · 2011-06-29FDA Approved: DOCETAXEL — Original Application (Baxter Healthcare Corporation)
FDA approved the original application for docetaxel by Baxter Healthcare Corporation, marking its initial U.S. approval as a cancer therapy.…